B. Liang et al. / Tetrahedron 63 (2007) 1981–1986
1985
C16H14N2O2: C 72.17, H 5.30, N 10.52, found C 72.00, H
5.31, N 10.34.
259–261 ꢀC; IR (KBr) nmax: 3381, 2932, 1613, 1515,
1
1402 cmꢁ1; H NMR (400 MHz, DMSO-d6): d 11.91 (s,
1H, NH), 9.33 (s, 1H, NH), 8.33–7.24 (m, 9H, Ar–H), 6.96
(d, J¼8.8 Hz, 1H, ]CH), 5.44 (d, J¼8.8 Hz, 1H, CH), 3.77
(s, 3H, OCH3); 13C NMR (100 MHz, DMSO-d6): d 162.1,
159.4, 152.8, 133.2, 131.4, 129.4, 128.7, 127.4, 114.2,
113.8, 79.2, 62.4, 55.5. Anal. Calcd for C17H16N2O2: C
72.84, H 5.75, N 10.00, found C 72.57, H 5.76, N 10.11.
4.2.8. 3,4-Dihydro-4-(4-hydroxy-3-methoxyphenyl)-6-
phenylpyrimidin-2(1H)-one 1h (firstly reported). White
solid; mp 267–268 ꢀC; IR (KBr) nmax: 3226, 2941, 1681,
1
1589, 1412 cmꢁ1; H NMR (400 MHz, DMSO-d6): d 8.83
(s, 1H, NH), 8.71–7.48 (m, 8H, Ar–H), 8.15 (s, 1H, NH),
7.11 (d, J¼4.8 Hz, 1H, ]CH), 5.32 (s, 1H, OH), 4.82 (d,
J¼4.8 Hz, 1H, CH); 13C NMR (100 MHz, DMSO-d6):
d 164.6, 163.1, 152.8, 136.6, 131.4, 129.4, 129.0, 128.0,
123.0, 121.5, 112.0, 111.4, 101.6, 55.9, 55.8. Anal. Calcd
for C17H16N2O3: C 68.91, H 5.44, N 9.45, found C 69.12,
H 5.33, N 9.63.
4.2.14. 3,4-Dihydro-4-(3,4-dimethoxyphenyl)-6-phenyl-
pyrimidin-2(1H)-one 1n (firstly reported). Yellow solid;
mp 243–245 ꢀC; IR (KBr) nmax: 3275, 2933, 1614, 1512,
1
1459 cmꢁ1; H NMR (400 MHz, DMSO-d6): d 11.95 (s,
1H, NH), 8.58 (s, 1H, NH), 8.58–7.44 (m, 8H, Ar–H), 7.82
(d, J¼8.4 Hz, 1H, ]CH), 7.06 (d, J¼8.4 Hz, 1H, CH),
3.91 (s, 3H, OCH3), 3.89 (s, 3H, OCH3); 13C NMR
(100 MHz, DMSO-d6): d 159.3, 151.8, 148.7, 131.3,
128.7, 127.5, 121.2, 111.4, 110.4, 79.1, 55.7, 55.6. Anal.
Calcd for C18H18N2O3: C 69.66, H 5.85, N 15.50, found C
69.65, H 5.84, N 9.01.
4.2.9. 3,4-Dihydro-4-(2-methoxyphenyl)-6-phenylpyri-
midin-2(1H)-one 1i (firstly reported). White solid; mp
266–267 ꢀC; IR (KBr) nmax: 3208, 2953, 1688, 1593,
1465 cmꢁ1 1H NMR (400 MHz, DMSO-d6): d 9.34 (s,
;
1H, NH), 8.51 (s, 1H, NH), 8.51–6.09 (m, 9H, Ar–H), 5.71
(d, J¼6.4 Hz, 1H, ]CH), 5.34 (d, J¼6.4 Hz, 1H, CH),
3.78 (s, 3H, OCH3); 13C NMR (100 MHz, DMSO-d6):
d 156.4, 153.0, 135.6, 134.5, 134.2, 132.5, 129.8, 128.6,
126.3, 126.0, 120.5, 111.2, 110.9, 97.5, 58.3, 55.4. Anal.
Calcd for C17H16N2O2: C 72.84, H 5.75, N 9.99, found C
71.89, H 5.88, N 10.00.
4.2.15. 4-(2-Chlorophenyl)-3,4-dihydro-6-phenylpyrimi-
din-2(1H)-one15 1o. White solid; mp 260–263 ꢀC; IR
1
(KBr) nmax: 3289, 2942, 1654, 1589, 1418 cmꢁ1; H NMR
(400 MHz, DMSO-d6): d 8.60 (s, 1H, NH), 8.15 (s, 1H,
NH), 7.42–7.15 (m, 9H, Ar–H), 5.45 (d, J¼4.4 Hz, 1H,
]CH), 5.12 (d, 1H, J¼2.8 Hz, CH); 13C NMR (100 MHz,
DMSO-d6): d 154.7, 145.7, 138.3, 135.8, 131.6, 129.5,
128.8, 128.6, 128.4, 128.1, 127.5, 125.5, 94.1, 54.3. Anal.
Calcd for C16H12Cl2N2O: C 60.21, H 3.79, N 8.78, Cl
22.21, found C 60.31, H 3.71, N 9.00, Cl 21.96.
4.2.10. 4-(4-tert-Butylphenyl)-3,4-dihydro-6-phenylpyri-
midin-2(1H)-one 1j (firstly reported). White solid; mp
238–240 ꢀC; IR (KBr) nmax: 3221, 2960, 1695, 1577,
1411 cmꢁ1 1H NMR (400 MHz, DMSO-d6): d 8.32 (s,
;
1H, NH), 7.45–7.12 (m, 9H, Ar–H), 5.27 (d, 1H,
J¼4.8 Hz, C]CH), 5.14 (d, 1H, J¼3.6 Hz, CH), 5.54 (s,
1H, NH), 1.45 (s, 6H, CH3); 13C NMR (100 MHz, DMSO-
d6): d 154.6, 143.1, 134.3, 128.6, 128.5, 128.2, 127.2,
126.4, 125.3, 136.5, 99.5, 53.5, 42.2, 30.8. Anal. Calcd for
C20H22N2O: C 78.40, H 7.24, N 9.14, found C 78.41, H
7.32, N 9.04.
4.2.16. Ethyl-4-(4-(5-(ethoxycarbonyl)-1,2,3,4-tetrahy-
dro-6-methyl-2-oxopyrimidin-4-yl)phenyl)-1,2,3,4-tetra-
hydro-6-methyl-2-oxopyrimidine-5-carboxylate 1p
(firstly reported). Slightly yellow solid; mp >350 ꢀC; IR
1
(KBr) nmax: 3355, 2976, 1701, 1646, 1456, 1375 cmꢁ1; H
NMR (400 MHz, pyridine-d6): d 9.16 (s, 4H, NH), 7.67–
7.14 (m, 4H, Ar–H), 5.11–5.14 (m, 2H, CH), 3.99–3.94
(m, 4H, CH2–R), 2.25–2.19 (m, 6H, H3C–C]C), 1.13–
1.03 (m, 6H, CH3–C); 13C NMR (100 MHz, pyridine-d6):
d 165.3, 152.1, 148.3, 143.9, 126.3, 99.2, 59.2, 53.7, 17.7,
14.1; HRMS (ESI) for C22H26N4O6 [M+Na] found (ex-
pected): 465.1756 (465.1759).
4.2.11. 4-(3,5-Dibromo-4-hydroxyphenyl)-3,4-dihydro-6-
phenylpyrimidin-2(1H)-one 1k (firstly reported). Slightly
red solid; mp 256–260 ꢀC; IR (KBr) nmax: 3276, 3089, 1656,
1553, 1408 cmꢁ1; 1H NMR (400 MHz, pyridine-d6): d 9.214
(s, 1H, NH), 8.21–7.56 (m, 9H, Ar–H), 6.45 (s, 1H, NH),
5.47 (d, J¼3.2 Hz, 1H, ]CH), 5.23 (d, J¼3.2 Hz, 1H,
CH), 2.84 (s, 1H, OH); 13C NMR (100 MHz, pyridine-d6):
d 156.7, 146.2, 136.5, 133.6, 130.5, 128.6, 124.8, 121.4,
113.8, 99.1, 55.4. Anal. Calcd for C16H12Br2N2O2: C
45.31, H 2.85, N 6.61, found C 45.25, H 2.78, N 6.55.
Acknowledgements
The work was supported by the Natural Science Foundation
of China (Grants 20272047, 20572086), the Gansu Natural
Science Foundation of China (3ZS051-A25-001) and Key
Laboratory of Eco-Environment-Related Polymer Material
(Northwest Normal University), Ministry of Education of
China.
4.2.12. 3,4-Dihydro-6-phenyl-4-p-tolylpyrimidin-2(1H)-
one15 1l. White solid; mp 248–250 ꢀC; IR (KBr) nmax
:
3235, 2920, 1650, 1570, 1402 cmꢁ1; H NMR (400 MHz,
DMSO-d6): d 9.24 (s, 1H, NH), 8.48 (s, 1H, NH), 7.84–
6.00 (m, 9H, Ar–H), 5.56 (d, J¼6.8 Hz, 1H, ]CH), 5.31
(d, J¼6.8 Hz, 1H, CH), 2.42 (s, 3H, CH3); 13C NMR
(100 MHz, DMSO-d6): d 157.5, 136.4, 133.4, 133.1,
132.5, 129.3, 128.4, 126.2, 125.6, 120.3, 111.1, 110.1,
99.3, 23.1. Anal. Calcd for C17H16N2O: C 77.25, H 6.10,
N 10.60, found C 77.32, H 5.99, N 10.61.
1
References and notes
1. Kappe, C. O. Eur. J. Med. Chem. 2000, 35, 1043–1052.
2. (a) Atwal, K. S.; Swanson, B. N.; Unger, S. E.; Floyd, D. M.;
Moreland, S.; Hedberg, A.; O’ Reilly, B. C. J. Med. Chem.
1991, 34, 806–811; (b) Rovnyak, G. C.; Atwal, K. S.;
Hedberg, A.; Kimball, S. D.; Moreland, S.; Gougoutas, J. Z.;
4.2.13. 3,4-Dihydro-4-(4-methoxyphenyl)-6-phenylpyri-
midin-2(1H)-one 1m (firstly reported). White solid; mp